Founder And Ceo
Current
Abbratech And Precision Biotools
Precision-targeted therapeutic antibodies based on our proprietary 'Epivolve' technology.
Dec 2020 - Present
AeroLeads people directory · profile
Michael Weiner Email & Phone Number
Founder of Abbratech, Precision Biotools and Encodia
at
Encodia
1 work email found
@encodia.com
10 phones found area 203, 619, 858, and 919
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
Founder of Abbratech, Precision Biotools and Encodia
Location
Branford, Connecticut, United States
Who is Michael Weiner? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Michael Weiner is listed as Founder of Abbratech, Precision Biotools and Encodia at Encodia, based in Branford, Connecticut, United States. AeroLeads shows a work email signal at encodia.com, phone signal with area code 203, 619, 858, 919, and a matched LinkedIn profile for Michael Weiner.
Michael Weiner previously worked as Founder and CEO at Abbratech And Precision Biotools and Co-Founder at Encodia. Michael Weiner holds Post-Doc, Physical Chemistry from Cornell University.
Company email context
Email format at Encodia
This section adds company-level context without repeating Michael Weiner's masked contact details.
{first_initial}{last}@encodia.com
86% confidence
AeroLeads found 1 current-domain work email signal for Michael Weiner. Compare company email patterns before reaching out.
Profile bio
About Michael Weiner
Serial Scientific Entrepreneur. Founder and CEO of Abbratech and Precision Biotools. Inventor of site-directed antibodies.Notable life sciences tools developed (all published in scientific peer reviewed literature and most issued US patents) include: 1st to clone and sequence BamHI (Ph.D. thesis, Cornell Univ.), 1st to code the use of a rolling hash computer algorithm for DNA analysis, sole inventor of QuikChange Mutagenesis, pCR-Script directional blunt-ended cloning method, paired-end DNA sequencing, emulsion PCR (454 Life Sciences), droplet PCR (RainDance Technologies), HT Y2H for protein::protein interaction, (GlaxoSmithKline), HT phage display for Ab discovery (Affomix), inventor of DNA bar-coded Luminex beads for multiplex DNA genotyping, expanded radix algorithm for more efficient DNA sequence storage (Illumina), invented the pMINERVA scFv to IgG cloning and expression system (AxioMx). Inventor in NextGen DNA sequencing, and NextGen Proteomics sequencingFounder of Affomix (proteomics, acquired by Illumina), AxioMx (proteomics, acquired by Abcam), GnuBio (NextGen DNA sequencing, acquired by BioRad), and Encodia (NextGen protein sequencing). Director of The Rothberg Institute for Childhood Diseases and CSO of 454 Life Sciences (NextGen DNA Sequencing, Acquired by Roche) and RainDance Technologies (microfluidics, acquired by BioRad).Co-author of papers and named inventor on numerous patents. Editor for BioTechniques and serves on several SABs and BoDs. Member of several NIH review panels and has been awarded over $30M in R01, R21, SBIR Phase I and II, Fast-track, Direct-to Phase II, U19 and U53 grant. Awarded DARPA funding. Winner of both Connecticut Entrepreneur of the year and CiteAb lifetime achievement awards.Ph.D. in Genetics from Cornell University cloning, sequencing and characterizing the psm genes of temperate bacteriophages of Bacillus species, including M.BamHI. Minors in Microbiol. and Biochem. Post-doc designing, synthesizing Thrombin, RNaseA genes, investigated protein refolding under Dr H. Scheraga (Dept of Physical Chemistry, Cornell University).Professional ceramicist, specializing in macro-crystalline glazes and image-transfer onto clay. Invented and submitted several novel methods for image transfer onto clay in Pottery Making Illustrated and has taught several ceramics workshops at Guilford Art Center and Wesleyan Pottery Studio.Scientific specialties: Tech dev: Genetics, Genomics, Mol. Biol., Proteomics, biol. applications in emulsions and small volumes (<50 pL), DNA sequencing, Bioeng., Instrumentation
Listed skills include Genomics, Molecular Biology, Biochemistry, Dna, and 19 others.
Current workplace
Michael Weiner's current company
Company context helps verify the profile and gives searchers a useful next step.
12 roles · 37 years
Michael Weiner work experience
A career timeline built from the work history available for this profile.
Co-Founder
CurrentWe are a privately held biotech company developing a highly-parallelized protein analysis platform. "Our vision is to transform biomedical research by delivering next-gen proteomics technology."
Jan 2017 - Present
Owner
Current
Next Generation Tile (Nextgen Tile)
Private outlet for sale of ceramics and other artwork.
May 2010 - Present
V.P. Research
AxioMx was acquired by Abcam on November 11, 2015. Being able to access the tools already in place at Abcam and leveraging the technology we developed at AxioMx will be an incredible opportunity. My immediate goal is to make this integration succeed with zero down-time.
Nov 2015 - Jan 2021
Founder And Chief Scientific Officer
Axiomx Inc. (Acquired By Abcam In 2015)
It currently takes 4-6 months to generate high-affinity, high specificity reagents. Through advances in automation, molecular biology and genetics, my AxioMx goal is to reduce this time period to less than 2 weeks.
Feb 2012 - Nov 2015
Founder And Scientific Consultant
Company founder and Scientific Consultant. GnuBio uses microfluidics and proprietary emulsion libraries to sequence DNA.
Jan 2008 - Jan 2014
Founder And Cso
Affomix Corp (Acquired By Illumina, Inc In 2010)
Company founder and CSO. Affomix developed automated methods to screen for antibodies against peptide and protein antigens. We invented the use of microemulsions for screening phage display libraries by fluorescence-activated cell sorting (FACS). Prior to the Illumina acquisition we brought in over $4MM in NIH grant and external contract funding and raised.
2006 - Jan 2012
V.P., Molecular Sciences
As one of the first employees at RainDance Technologies, M.Weiner invented and helped develop a droplet tracking scheme for emulsion library constituents and co-invented the use of emulsion PCR for target-sequence amplification for Next-generation DNA sequencers. Additional applications he developed included single-enzyme and single-cell analysis in.
2003 - 2007
~4 yrs
Director
Rothberg Institute
Developed phage-display and emulsion-based screening methodology for antibody-therapeutic treatments for tuberous sclerosis complex (TSC). Led team that developed first cell-based model system for TSC. Led team that analyzed TSC tissues for up-regulated genes involved in TSC tumors.
2002 - 2006
~4 yrs
V.P., Molecular Sciences
Dr Weiner co-invented the first commercial Next-generation DNA sequencer and was a co-inventor of emulsion PCR for template preparation for Next-generation DNA sequencing. He led research and development for both the Molecular Biology and Engineering teams for the first 3 years of 454's existence and brought in over $10MM in NIH funding.
2000 - 2003
~3 yrs
Head, Dept. Of Genomic Sciences
Invented and developed: 1) Luminex-based SNP genotyping using DNA ZipCoded beads, 2) automated high-throughput yeast two-hybrid system, 3) new multifunctional expression vectors for baculoviral and adenoviral expression in insect and mammalian cells. Head of department responsible for DNA sequencing and gene expression analysis for the RTP site and a.
1995 - 2000
~5 yrs
Sr. Staff Scientist
At Stratagene Dr Weiner invented and developed several products for the reagent marketplace, including: Quikchange, (a method for site-directed mutagenesis) and pCRScript, a system for cloning PCR fragments.
1989 - 1995
~6 yrs
4 education records
Michael Weiner education
Post-Doc, Physical Chemistry
Cornell University
Ph.D., Genetics
Cornell University
B. Sci., Microbiology And Immunology
Penn State University
H.S., Academic
Council Rock High School
FAQ
Frequently asked questions about Michael Weiner
Quick answers generated from the profile data available on this page.
What company does Michael Weiner work for?
Michael Weiner works for Encodia.
What is Michael Weiner's role at Encodia?
Michael Weiner is listed as Founder of Abbratech, Precision Biotools and Encodia at Encodia.
What is Michael Weiner's email address?
AeroLeads has found 1 work email signal at @encodia.com for Michael Weiner at Encodia.
What is Michael Weiner's phone number?
AeroLeads has found 10 phone signal(s) with area code 203, 619, 858, 919 for Michael Weiner at Encodia.
Where is Michael Weiner based?
Michael Weiner is based in Branford, Connecticut, United States while working with Encodia.
What companies has Michael Weiner worked for?
Michael Weiner has worked for Abbratech And Precision Biotools, Encodia, Next Generation Tile (Nextgen Tile), Abcam, and Axiomx Inc. (Acquired By Abcam In 2015).
How can I contact Michael Weiner?
You can use AeroLeads to view verified contact signals for Michael Weiner at Encodia, including work email, phone, and LinkedIn data when available.
What schools did Michael Weiner attend?
Michael Weiner holds Post-Doc, Physical Chemistry from Cornell University.
What skills is Michael Weiner known for?
Michael Weiner is listed with skills including Genomics, Molecular Biology, Biochemistry, Dna, Dna Sequencing, Biotechnology, Genetics, and Proteomics.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial